November 24, 2025
Novel Sulfated Oligosaccharide DP9: A Potent Galectin-3 Inhibitor for Pancreatic Cancer Therapy
On October 30, 2025, Liu et al. from Guangdong Provincial Key Laboratory of Marine Biotechnology published an article in the journal Marine Drugs titled "Novel Sulfated Oligosaccharide DP9 from Marine Algae, Gracilaria lemaneiformis: A Potent Galectin-3 Inhibitor for Pancreatic Cancer Therapy". The paper investigates the discovery and structural characterization of a novel Sulfated Oligosaccharide, designated […]
Read More >